Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Long-term follow-up of testicular cancer patients shows no predisposition to osteoporosis.

Murugaesu N, Powles T, Bestwick J, Oliver RT, Shamash J.

Osteoporos Int. 2009 Sep;20(9):1627-30. doi: 10.1007/s00198-008-0793-x. Epub 2008 Nov 22.

PMID:
19030945
2.
3.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

4.

Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.

Pichette V, Bonnardeaux A, Prudhomme L, Gagné M, Cardinal J, Ouimet D.

Am J Kidney Dis. 1996 Jul;28(1):105-14.

PMID:
8712204
5.

Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma.

Brown JE, Ellis SP, Silcocks P, Blumsohn A, Gutcher SA, Radstone C, Hancock BW, Hatton MQ, Coleman RE.

Clin Cancer Res. 2006 Nov 1;12(21):6480-6.

6.
7.

Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer.

Ondrusova M, Ondrus D, Dusek L, Spanikova B.

Neoplasma. 2009;56(6):473-9.

PMID:
19728753
8.

Do Patients After Chondrosarcoma Treatment Have Age-appropriate Bone Mineral Density in the Long Term?

Hobusch GM, Tiefenboeck TM, Patsch J, Krall C, Holzer G.

Clin Orthop Relat Res. 2016 Jun;474(6):1508-15. doi: 10.1007/s11999-016-4741-3. Epub 2016 Feb 16.

9.
10.

Screening for osteopenia and osteoporosis: selection by body composition.

Michaëlsson K, Bergström R, Mallmin H, Holmberg L, Wolk A, Ljunghall S.

Osteoporos Int. 1996;6(2):120-6.

PMID:
8704349
11.

[Prevalence of osteoporosis in male patients with risk factors].

Audran M, Cortet B.

Presse Med. 2011 Nov;40(11):e489-98. doi: 10.1016/j.lpm.2011.08.002. Epub 2011 Oct 2. French.

PMID:
21964043
12.

Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation.

Seland M, Smeland KB, Bjøro T, Falk RS, Fosså SD, Gjesdal CG, Godang K, Holte H, Svartberg J, Syversen U, Bollerslev J, Kiserud CE.

Acta Oncol. 2017 Apr;56(4):590-598. doi: 10.1080/0284186X.2016.1267870. Epub 2017 Jan 12.

PMID:
28077016
13.

Prevalence of vertebral fractures independent of BMD and anticancer treatment in patients with testicular germ cell tumors.

Willemse PM, Hamdy NA, van Wulften L, van Steijn-van Tol AQ, Putter H, Osanto S.

J Clin Endocrinol Metab. 2010 Nov;95(11):4933-42. doi: 10.1210/jc.2010-0093. Epub 2010 Aug 11.

PMID:
20702527
14.

Detailed analyses of periarticular osteoporosis in rheumatoid arthritis.

Alenfeld FE, Diessel E, Brezger M, Sieper J, Felsenberg D, Braun J.

Osteoporos Int. 2000;11(5):400-7.

PMID:
10912841
15.

[Factors associated with osteopenia and osteoporosis in women undergoing bone mineral density test].

Veiga Silva AC, da Rosa MI, Fernandes B, Lumertz S, Diniz RM, dos Reis Damiani ME.

Rev Bras Reumatol. 2015 May-Jun;55(3):223-8. doi: 10.1016/j.rbr.2014.08.012. Epub 2014 Oct 24. Portuguese.

16.

Does the crack silently break the back? Long-term follow-up and assessment of risk factors for regional osteoporosis following tibial shaft fractures.

Khalid M, Heffernan G, Brannigan A, Burke T, Grace P, Lyons D.

J Clin Densitom. 2005 Winter;8(4):467-71.

PMID:
16311433
17.

Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.

Beerhorst K, Tan IY, De Krom M, Verschuure P, Aldenkamp AP.

Acta Neurol Scand. 2013 Oct;128(4):273-80. doi: 10.1111/ane.12118. Epub 2013 Mar 6.

PMID:
23461582
18.
19.

Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan.

Negredo E, Bonjoch A, Gómez-Mateu M, Estany C, Puig J, Perez-Alvarez N, Rosales J, di Gregorio S, del Rio L, Gómez G, Clotet B.

PLoS One. 2012;7(10):e46031. doi: 10.1371/journal.pone.0046031. Epub 2012 Oct 8.

20.

The value of calcaneal bone mass measurement using a dual X-ray laser Calscan device in risk screening for osteoporosis.

Kayalar G, Cevikol A, Yavuzer G, Sanisoglu Y, Cakci A, Arasil T.

Clinics (Sao Paulo). 2009;64(8):757-62. doi: 10.1590/S1807-59322009000800008.

Supplemental Content

Support Center